Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 September 2022 | Story Jóhann Thormählen | Photo iStock
Cervical cancer awareness ribbon
Cervical Cancer Awareness Month is observed in September in South Africa to encourage women to go for screening to prevent it.

Cervical cancer is the second most common cancer among women in South Africa, and many die from it each year – but it can be prevented.

According to Dr Arina Meyer, medical practitioner in Kovsie Health at the University of the Free State, this is one of the reasons why it is important to be informed, take precautions, and raise awareness about the disease.

Cervical Cancer Awareness Month is observed in September in South Africa with the aim of encouraging women to go for screening to prevent it.

Although medical statistics paint a bleak picture, Meyer says there is hope. “It is important to know that cervical cancer can be prevented. And when it is diagnosed early, it can be treated.”

Statistics and causes

According to her, figures show the occurrence of cervical cancer to be between 22,8 and 27 per 100 000 women in South Africa. 

“More than 5 700 new cases are reported each year, as well as more than 3 000 deaths. Cervical cancer is the second most common cancer – after skin cancer – in South Africa.”

Meyer says when one look at these numbers, it is important to commemorate Cervical Cancer Awareness Month, as women need to be informed about their annual check-up, possible symptoms, and signs of the cancer.

Most cervical cancers are caused by the human papillomavirus (HPV), which is transmitted through sexual contact. Therefore, the HPV is seen as a sexually transmitted disease.

“There are different types of HPV. Some cause cervical cancer and other genital warts. One can develop one or both conditions, depending on the type of virus you have,” says Meyer.

Prevention and reducing the risk

According to her, preventative action is the best method. Going for a cervical screening every year when you become sexually active, such as a Pap smear or Pap test, will help in the early detection and removal of abnormal cells.

There is also a vaccine for protection against HPV, which is available from the age of nine. Meyer says there are two vaccines in South Africa.

“By getting the vaccine early, before any sexual activity, the spread of HPV – and therefore cervical cancer – can be prevented. Up to 90% of cancers can be prevented.
“Unfortunately, if someone has already been infected by the HPV, it cannot be treated by the vaccine.”

The UFS medical practitioner says the best ways to reduce the risk of cervical cancer are to go for an annual Pap smear, a follow-up after an abnormal test result, the vaccine, safe sex, and to stop smoking.

News Archive

UFS research on yeast nanorobotics
2006-05-09

Ten members from the University of the Free State's (UFS) Lipid Biotechnology Research Group in the Department of Microbial, Biochemical and Food Biotechnology will be presenting their research  on yeast nanorobotics (nanotechnology) at three international conferences in Europe during May and June 2006.

 

It is one of the biggest group of students from the department to present their research overseas.  

The conferences to be attended include the 2nd International Conference on Non Mammalian Eicosanoids, Bioactive Lipids and Plant Oxylipins held in Berlin, Germany; the 3rd European Conference on Computational Mechanics (ECCM-2006) held in Lisbon, Portugal and the 25th International Specialised Symposium on Yeasts (ISSY 2006) held in Helsinki, Finland.  The UFS Lipid Biotechnology Group is also co-organising the conference in Berlin.

The group members are in front from the left Ms Chantel Swart (M Sc student), Ms Ntsoaki Leeuw (M Sc student) and Ms Monique Goldblatt (M Sc student).
Middle from the left Mr Olihile Sebolai (Ph D student and recipient of the Free State Premier Excellence Award), Ms Ané van Heerden (M Sc student) and Dr Catrine Strauss (post-doctoral student).
At the back are from the left Mr Desmond Ncango (M Sc), Dr Carlien Pohl (Senior Researcher), Prof Pieter van Wyk (Head: UFS Center for Confocal and Electron Microscopy) and Prof Lodewyk Kock (Head: UFS Lipid Biotechnology Group).
Photo: Stephen Collett

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept